Group 1 - The core viewpoint of the news is that Dabo Medical has seen a stock price increase of 5.09%, reaching 55.10 CNY per share, with a total market capitalization of 22.812 billion CNY [1] - Dabo Medical specializes in the production, research, and sales of high-value medical consumables, with its main revenue sources being trauma products (38.68%), spinal products (17.95%), minimally invasive surgical products (16.34%), joint products (10.37%), and others [1] Group 2 - From the perspective of fund holdings, one fund under Jiashi Fund has Dabo Medical as a top ten holding, with 204,000 shares held, accounting for 0.94% of the fund's net value [2] - Jiashi Research Selected Mixed Fund (070013) has achieved a year-to-date return of 11.47% and a one-year return of 25.29%, ranking 5506 out of 8173 and 5455 out of 7996 respectively [2] Group 3 - The fund manager of Jiashi Research Selected Mixed Fund is Chen Yong, who has been in position for 3 years and 117 days, and Xiao Mi, who has been in position for 8 years and 272 days [3] - The total asset size of Jiashi Research Selected Mixed Fund is 783 million CNY, while the total asset size of Xiao Mi's fund is 5.028 billion CNY [3]
大博医疗股价涨5.09%,嘉实基金旗下1只基金重仓,持有20.4万股浮盈赚取54.47万元